Optimizing adenoviral transduction of endothelial cells under flow conditions
- PMID: 22207207
- DOI: 10.1007/s11095-011-0631-2
Optimizing adenoviral transduction of endothelial cells under flow conditions
Abstract
Purpose: To target adenoviral vectors to cells of the vasculature and shielding vectors from inactivation by the immune system.
Methods: Complexes of reporter gene expressing adenoviral vectors with positively charged magnetic nanoparticles were formed by electrostatic interaction in presence or absence of additional negatively charged poly(ethylene glycol)-based polymer. Transduction of HUVEC was analyzed in vitro under flow. Protection from inactivation by the immune system was analyzed by pre-incubation of AdV and complexes with neutralizing antibodies and subsequent reporter protein analysis of infected cells.
Results: Physical association of AdV with MNP and polymers was demonstrated by radioactive labelling of components and co-sedimentation in a magnetic field. Ad-MNP+/-polymer resulted in efficient transduction of HUVEC, depending on MOI and flow rate in presence of magnetic field, whereas no transduction was observed without complex formation with MNP or in absence of magnetic field. Association with MNP did result in protection from neutralizing antibodies, with slightly increased protection provided by the polymer.
Conclusions: Complex formation of AdV with MNP is a viable means for targeting of vectors to areas of magnetic field gradient. Additional coating with polymer might proof useful in protection from inactivation by the immune system.
Similar articles
-
Magnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells.Mol Pharm. 2009 Sep-Oct;6(5):1380-7. doi: 10.1021/mp900017m. Mol Pharm. 2009. PMID: 19496618 Free PMC article.
-
Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression.Mol Ther. 2008 Jul;16(7):1276-82. doi: 10.1038/mt.2008.86. Epub 2008 May 6. Mol Ther. 2008. PMID: 18461056
-
Transduction of adenovirus vectors modified with cell-penetrating peptides.Peptides. 2009 Aug;30(8):1548-52. doi: 10.1016/j.peptides.2009.05.017. Epub 2009 May 23. Peptides. 2009. PMID: 19467282
-
Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide.Mol Ther. 2008 Jan;16(1):16-29. doi: 10.1038/sj.mt.6300321. Epub 2007 Oct 2. Mol Ther. 2008. PMID: 17912234 Review.
-
Advances in gene transfer into haematopoietic stem cells by adenoviral vectors.Expert Opin Biol Ther. 2002 Dec;2(8):847-56. doi: 10.1517/14712598.2.8.847. Expert Opin Biol Ther. 2002. PMID: 12517264 Review.
Cited by
-
Optimization of magnetic nanoparticle-assisted lentiviral gene transfer.Pharm Res. 2012 May;29(5):1255-69. doi: 10.1007/s11095-011-0660-x. Epub 2012 Jan 25. Pharm Res. 2012. PMID: 22274554
-
Silica-iron oxide magnetic nanoparticles modified for gene delivery: a search for optimum and quantitative criteria.Pharm Res. 2012 May;29(5):1344-65. doi: 10.1007/s11095-011-0661-9. Epub 2012 Jan 6. Pharm Res. 2012. PMID: 22222384
-
Formulation design facilitates magnetic nanoparticle delivery to diseased cells and tissues.Nanomedicine (Lond). 2014 Mar;9(3):469-85. doi: 10.2217/nnm.14.4. Epub 2014 Mar 19. Nanomedicine (Lond). 2014. PMID: 24646020 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources